Regeneron Pharmaceuticals, Inc. vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
8
Buy
Overall
6.5
Hold
Quality
Health
Growth
Valuation
Sentiment
REGN
Clean balance sheet with low leverage (0.1× debt-to-equity).
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $877.73 (+24.6%)
28 analysts
HOLD
Target $29.00 (+8.7%)
27 analysts
Fundamentals
REGN
PFE
17.2×
Trailing P/E
19.6×
13.3×
Forward P/E
9.5×
29.6%
Profit Margin
12.4%
44.6%
Gross Margin
75.8%
14.5%
ROE
8.9%
19.0%
Revenue Growth
-1.2%
-7.2%
Earnings Growth
—
0.40
Beta
0.39
—
Price / Book
—
$73.9B
Market Cap
$151.8B
$476 – $821
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.